Lv5
1070 积分 2024-06-11 加入
Physiologically Based Pharmacokinetic Modelling to Describe the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone According to Cytochrome P450 2D6 Phenotypes
1天前
待确认
Evaluation of Concomitant Antiretrovirals and CYP2C9/CYP2C19 Polymorphisms on the Pharmacokinetics of Etravirine
20天前
已完结
Prospective DDI Risk Assessment of Vicasinabin with PBPK Modeling by Integrating In Vitro Data
20天前
已完结
Physiologically Based Pharmacokinetic (PBPK) Modeling of Pitavastatin and Atorvastatin to Predict Drug-Drug Interactions (DDIs)
21天前
已完结
Prospective DDI Risk Assessment of Vicasinabin with PBPK Modeling by Integrating In Vitro Data
22天前
已完结
Darunavir/Ritonavir Pharmacokinetics Following Coadministration With Clarithromycin in Healthy Volunteers
1个月前
已完结
Integrating artificial intelligence and physiologically based pharmacokinetic modeling to predict in vitro and in vivo fate of amorphous solid dispersions
2个月前
已完结
HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833
2个月前
已完结
Prediction of CYP3A-Mediated Drug-Drug Interactions Using Human Hepatocytes Suspended in Human Plasma
2个月前
已完结
Physiologically-Based Pharmacokinetic Modeling of PAXLOVID™ with First-Order Absorption Kinetics
2个月前
已完结
皖公网安备34019202002308
